Copyright: ©Author(s) 2026.
World J Cardiol. Jun 26, 2026; 18(6): 119376
Published online Jun 26, 2026. doi: 10.4330/wjc.119376
Published online Jun 26, 2026. doi: 10.4330/wjc.119376
Table 1 Baseline characteristics based on estimated glomerular filtration rate values estimated with different equations, n (%)/median (interquartile range)
| Variable | Total | MDRD, < 90 mL/minute (n = 2069, 63.5%) | c-aMDRD, < 90 mL/minute (n = 1466, 45.0%) | CKD-EPI, < 90 mL/minute (n = 2436, 74.8%) | aCKD-EPI, < 90 mL/minute (n = 1878, 57.7%) | cCKD-EPI, < 90 mL/minute (n = 3112, 95.5%) |
| Age | 70 (67-75) | 71a (68-77) | 72a (68-78) | 71a (68-77) | 72a (68-78) | 70a (67-75) |
| Male | 1430 (43.9) | 906 (43.8) | 788a (53.1) | 1125a (46.2) | 855a (45.5) | 1428a (45.9) |
| Hypertension | 1740 (53.4) | 1147a (55.4) | 848a (57.8) | 1349a (55.4) | 1074a (57.2) | 1674 (53.8) |
| Diabetes | 639 (19.6) | 374a (18.1) | 283 (19.3) | 454a (18.6) | 351 (18.7) | 599a (19.2) |
| CHD | 1050 (32.2) | 703a (34) | 511a (34.9) | 838a (34.4) | 665a (35.4) | 1008 (32.4) |
| Stroke | 612 (18.8) | 394 (19) | 285 (19.4) | 458 (18.8) | 355 (18.9) | 588 (18.9) |
| Smoking | 807 (24.8) | 518 (25) | 430a (29.3) | 606 (24.9) | 475 (25.3) | 805a (25.9) |
| Alcoholic | 556 (17.1) | 334 (16.1) | 236 (16.1) | 409 (16.8) | 303 (16.1) | 537 (17.3) |
| BMI | 24.4 (22.2-26.6) | 24.4a (22.4-26.8) | 24.6a (22.5-26.9) | 24.4a (22.3-26.7) | 24.5a (22.5-26.9) | 24.4 (22.2-26.6) |
| TC | 5.04 (4.41-5.73) | 5.06a (4.45-5.75) | 5.02 (4.40-5.71) | 5.04 (4.42-5.74) | 5.04 (4.44-5.74) | 5.03 (4.40-5.73) |
| LDL | 3.09 (2.53-3.70) | 3.11a (2.57-3.72) | 3.08 (2.55-3.68) | 3.09 (2.55-3.71) | 3.10 (2.56-3.71) | 3.08 (2.53-3.69) |
| HDL | 1.35 (1.13-1.61) | 1.34 (1.13-1.61) | 1.34 (1.11-1.62) | 1.34 (1.13-1.62) | 1.34 (1.12-1.63) | 1.34 (1.13-1.61) |
| TG | 1.38 (1.04-1.90) | 1.35 (1.03-1.87) | 1.36 (1.03-1.88) | 1.36 (1.03-1.88) | 1.36 (1.03-1.88) | 1.38 (1.04-1.90) |
| WBC | 5.66 (4.83-6.66) | 5.74a (4.92-6.72) | 5.78a (4.99-6.84) | 5.7a (4.87-6.71) | 5.75a (4.93-6.74) | 5.66 (4.83-6.66) |
| Albumin | 47 (45-49) | 47a (45-49) | 47a (45-48) | 47a (45-49) | 47a (45-48) | 47 (45-49) |
| Uric acid | 325 (275-380) | 340a (290-400) | 355a (301-416) | 335a (286-393) | 343a (292-403) | 327a (279-382) |
Table 2 Association between clinical outcomes and estimated glomerular filtration rate calculated with different equations, n (%)
| Equation | Event | eGFR(mL/minute) | P value | ||
| ≥ 90 | 60-90 | < 60 | |||
| MDRD | MACE | 113 (9.5) | 190 (10.5) | 40 (15.9)1 | 0.011 |
| Cardiovascular mortality | 16 (1.3) | 42 (2.3) | 19 (7.6)1 | < 0.001 | |
| All-cause mortality | 54 (4.5) | 95 (5.2) | 53 (21.1)1 | < 0.001 | |
| Event-free | 1037 (87.3) | 1575 (86.6) | 177 (70.5)1 | < 0.001 | |
| c-aMDRD | MACE | 170 (9.5) | 137 (10.7) | 36 (19.4)1 | < 0.001 |
| Cardiovascular mortality | 32 (1.8) | 27 (2.1) | 18 (9.7)1 | < 0.001 | |
| All-cause mortality | 82 (4.6) | 75 (5.9) | 45 (24.2)1 | < 0.001 | |
| Event-free | 1571 (87.7) | 1095 (85.5) | 123 (66.1)1 | < 0.001 | |
| CKD-EPI | MACE | 71 (8.6) | 224 (10.7) | 48 (14.4)1 | 0.015 |
| Cardiovascular mortality | 7 (0.9)2 | 46 (2.2) | 24 (7.2)1 | < 0.001 | |
| All-cause mortality | 26 (3.2)2 | 111 (5.3) | 65 (19.5)1 | < 0.001 | |
| Event-free | 731 (89)2 | 1814 (86.3) | 244 (73.3)1 | < 0.001 | |
| aCKD-EPI | MACE | 122 (8.8)2 | 180 (11.1) | 41 (16.3)1 | 0.001 |
| Cardiovascular mortality | 12 (0.9)2 | 45 (2.8) | 20 (7.9)1 | < 0.001 | |
| All-cause mortality | 45 (3.3)2 | 102 (6.3) | 55 (21.8)1 | < 0.001 | |
| Event-free | 1224 (88.8)2 | 1389 (85.4) | 176 (69.8)1 | < 0.001 | |
| cCKD-EPI | MACE | 12 (8.3) | 254 (9.9) | 77 (14.3)1 | 0.006 |
| Cardiovascular mortality | 1 (0.7) | 41 (1.6) | 35 (6.5)1 | < 0.001 | |
| All-cause mortality | 6 (4.1) | 109 (4.2) | 87 (16.2)1 | < 0.001 | |
| Event-free | 128 (88.3) | 2252 (87.5) | 409 (76.0)1 | < 0.001 | |
Table 3 Prediction of major adverse cardiovascular events by estimated glomerular filtration rate calculated with different equations
| eGFR (mL/minute) | ||||
| Equation | Cox | ≥ 90 | 60-90 | < 60 |
| MDRD | Event | 113/1188 | 190/1818 | 40/251 |
| HR | 1.08 | 1 | 1.15 | |
| 95%CI | 0.84-1.39 | 0.79-1.67 | ||
| P value | 0.54 | 0.46 | ||
| c-aMDRD | Event | 170/1791 | 137/1280 | 36/186 |
| HR | 1.18 | 1 | 1.59 | |
| 95%CI | 0.92-1.51 | 1.06-2.38 | ||
| P value | 0.18 | 0.026 | ||
| CKD-EPI | Event | 71/821 | 224/2103 | 48/333 |
| HR | 1.21 | 1 | 0.87 | |
| 95%CI | 0.89-1.65 | 0.62-1.24 | ||
| P value | 0.21 | 0.45 | ||
| aCKD-EPI | Event | 122/1379 | 180/1626 | 41/252 |
| HR | 1.14 | 1 | 1.12 | |
| 95%CI | 0.87-1.48 | 0.77-1.62 | ||
| P value | 0.34 | 0.55 | ||
| cCKD-EPI | Event | 12/145 | 254/2574 | 77/538 |
| HR | 1.17 | 1 | 0.79 | |
| 95%CI | 0.62-2.18 | 0.58-1.08 | ||
| P value | 0.63 | 0.14 | ||
Table 4 Assessment of the discrimination ability of different estimated glomerular filtration rate equations
| MACE | CV mortality | All-cause mortality | Event-free | |||||
| ΔAUC | P value | ΔAUC | P value | ΔAUC | P value | ΔAUC | P value | |
| MDRD and c-aMDRD | -0.06 | 0.089 | 0.002 | 0.744 | -0.004 | 0.372 | -0.007 | 0.027 |
| MDRD and CKD-EPI | -0.025 | < 0.001 | -0.059 | < 0.001 | -0.051 | < 0.001 | -0.032 | < 0.001 |
| MDRD and aCKD-EPI | -0.024 | < 0.001 | -0.059 | < 0.001 | -0.049 | < 0.001 | -0.030 | < 0.001 |
| MDRD and cCKD-EPI | -0.034 | < 0.001 | -0.057 | < 0.001 | -0.050 | < 0.001 | -0.041 | < 0.001 |
| c-aMDRD and CKD-EPI | -0.019 | < 0.001 | -0.061 | < 0.001 | -0.047 | < 0.001 | -0.025 | < 0.001 |
| c-aMDRD and aCKD-EPI | -0.018 | 0.001 | -0.061 | < 0.001 | -0.046 | < 0.001 | -0.024 | < 0.001 |
| c-aMDRD and cCKD-EPI | -0.028 | < 0.001 | -0.059 | < 0.001 | -0.047 | < 0.001 | -0.035 | < 0.001 |
| CKD-EPI and aCKD-EPI | 0.001 | 0.075 | 0.000 | 0.876 | 0.001 | 0.069 | 0.002 | 0.003 |
| CKD-EPI and cCKD-EPI | -0.009 | 0.118 | 0.002 | 0.870 | 0.000 | 0.981 | -0.009 | 0.067 |
| aCKD-EPI and cCKD-EPI | -0.010 | 0.093 | 0.002 | 0.887 | -0.001 | 0.885 | -0.011 | 0.038 |
- Citation: Aili A, Li RY, Mohammed AA, Zhao S, Li MR, Li HN, Xu YW, Zhang Y. Prognostic value of glomerular-filtration-rate estimated by common and modified Asian/Chinese equations for cardiovascular outcomes in elderly Chinese individuals. World J Cardiol 2026; 18(6): 119376
- URL: https://www.wjgnet.com/1949-8462/full/v18/i6/119376.htm
- DOI: https://dx.doi.org/10.4330/wjc.119376